The apoptotic pathway as a therapeutic target in sepsis.
暂无分享,去创建一个
[1] L. Doughty,et al. In vivo delivery of caspase-8 or Fas siRNA improves the survival of septic mice. , 2005, Blood.
[2] R. Rossaint,et al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. , 2005, The New England journal of medicine.
[3] J. Lukens,et al. Increased Fas ligand expression of CD4+ T cells by HCV core induces T cell‐dependent hepatic inflammation , 2005, Journal of leukocyte biology.
[4] C. Chung,et al. Leukocyte apoptosis and its significance in sepsis and shock , 2005, Journal of leukocyte biology.
[5] C. Whitacre,et al. Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade. , 2005, The journal of peptide research : official journal of the American Peptide Society.
[6] J. Nyengaard,et al. Endotoxemia-induced Lymphocyte Apoptosis Is Augmented by a Hyperinsulinemic–Euglycemic Clamp , 2005, Anesthesiology.
[7] Charles Natanson,et al. Novel therapies for sepsis: a review. , 2005, The Journal of trauma.
[8] T. Iba,et al. Activated protein C improves the visceral microcirculation by attenuating the leukocyte-endothelial interaction in a rat lipopolysaccharide model , 2005, Critical care medicine.
[9] Jerry A Nick,et al. Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. , 2004, Blood.
[10] Mark E. Davis,et al. Lack of interferon response in animals to naked siRNAs , 2004, Nature Biotechnology.
[11] C. Natanson,et al. Recombinant Human Activated Protein C in Sepsis: Assessing Its Clinical Use , 2004, The American journal of the medical sciences.
[12] Xiaodong Wang,et al. A Small Molecule Smac Mimic Potentiates TRAIL- and TNFα-Mediated Cell Death , 2004, Science.
[13] S. Dowdy,et al. Targeting Apoptotic Pathways in Cancer Cells , 2004, Science.
[14] S. Korsmeyer,et al. Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix , 2004, Science.
[15] Ping Wang,et al. Adrenomedullin and Adrenomedullin Binding Protein-1 Attenuate Vascular Endothelial Cell Apoptosis in Sepsis , 2004, Annals of surgery.
[16] A. Badley,et al. Improved survival in experimental sepsis with an orally administered inhibitor of apoptosis , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[17] Charles Natanson,et al. Meta-Analysis: The Effect of Steroids on Survival and Shock during Sepsis Depends on the Dose , 2004, Annals of Internal Medicine.
[18] Ursula Bommhardt,et al. Akt Decreases Lymphocyte Apoptosis and Improves Survival in Sepsis1 , 2004, The Journal of Immunology.
[19] D. Nelson,et al. Leukocyte and endothelial cell interactions in sepsis: Relevance of the protein C pathway , 2004, Critical care medicine.
[20] O. Schmitz,et al. Acute Hyperinsulinemia Restrains Endotoxin-induced Systemic Inflammatory Response: An Experimental Study in a Porcine Model , 2004, Anesthesiology.
[21] S. Oyadomari,et al. Roles of CHOP/GADD153 in endoplasmic reticulum stress , 2004, Cell Death and Differentiation.
[22] J. Gjedsted,et al. The roles of insulin and hyperglycemia in sepsis pathogenesis , 2004, Journal of leukocyte biology.
[23] José A Fernández,et al. Activated Protein C Prevents Neuronal Apoptosis via Protease Activated Receptors 1 and 3 , 2004, Neuron.
[24] H. Pircher,et al. IFN-γ Promotes Fas Ligand- and Perforin-Mediated Liver Cell Destruction by Cytotoxic CD8 T Cells1 , 2004, The Journal of Immunology.
[25] B. Pedersen,et al. Effect of hyperglycemia and hyperinsulinemia on the response of IL-6, TNF-alpha, and FFAs to low-dose endotoxemia in humans. , 2004, American journal of physiology. Endocrinology and metabolism.
[26] W. Schobersberger,et al. Association of endogenous G-CSF with anti-inflammatory mediators in patients with acute respiratory distress syndrome. , 2003, Journal of Interferon and Cytokine Research.
[27] W. Ruf,et al. Activated protein C signals through the thrombin receptor PAR1 in endothelial cells , 2003, Journal of endotoxin research.
[28] N. H. Steigbigel. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock , 2003, Current infectious disease reports.
[29] I. Chaudry,et al. Inhibition of Fas/Fas ligand signaling improves septic survival: differential effects on macrophage apoptotic and functional capacity , 2003, Journal of leukocyte biology.
[30] D. Annane,et al. Corticosteroids in Sepsis: From Bench to Bedside? , 2003, Shock.
[31] Robert H. Silverman,et al. Activation of the interferon system by short-interfering RNAs , 2003, Nature Cell Biology.
[32] T. Caserta,et al. Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties , 2003, Apoptosis.
[33] R. Iggo,et al. Induction of an interferon response by RNAi vectors in mammalian cells , 2003, Nature Genetics.
[34] M. Manns,et al. Caspase 8 small interfering RNA prevents acute liver failure in mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[35] Mouldy Sioud,et al. Gene silencing by systemic delivery of synthetic siRNAs in adult mice. , 2003, Journal of molecular biology.
[36] José A Fernández,et al. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective , 2003, Nature Medicine.
[37] Judy Lieberman,et al. RNA interference targeting Fas protects mice from fulminant hepatitis , 2003, Nature Medicine.
[38] B. Grinnell,et al. Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-&kgr;B , 2002, Critical care medicine.
[39] C. Coopersmith,et al. Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. , 2002, JAMA.
[40] A. Bell,et al. A mechanism of cell survival: sequestration of Fas by the HGF receptor Met. , 2002, Molecular cell.
[41] E. Ivers,et al. Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock , 2001 .
[42] I. Chaudry,et al. Inhibition of Fas signaling prevents hepatic injury and improves organ blood flow during sepsis. , 2001, Surgery.
[43] G. Clermont,et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.
[44] Charles A. Janeway,et al. INAUGURAL ARTICLE by a Recently Elected Academy Member:How the immune system works to protect the host from infection: A personal view , 2001 .
[45] I. Chaudry,et al. Increased apoptosis in lamina propria B cells during polymicrobial sepsis is FasL but not endotoxin mediated. , 2001, American journal of physiology. Gastrointestinal and liver physiology.
[46] L. Gelbert,et al. Gene Expression Profile of Antithrombotic Protein C Defines New Mechanisms Modulating Inflammation and Apoptosis* , 2001, The Journal of Biological Chemistry.
[47] Berislav V. Zlokovic,et al. Anti-Inflammatory, Antithrombotic, and Neuroprotective Effects of Activated Protein C in a Murine Model of Focal Ischemic Stroke , 2001, Circulation.
[48] L. Moldawer,et al. Apoptosis in sepsis: a new target for therapeutic exploration , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[49] J Ean,et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.
[50] R. Hotchkiss,et al. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte , 2000, Nature Immunology.
[51] P. Ward,et al. Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis. , 2000, The Journal of clinical investigation.
[52] P. Krammer,et al. CD95's deadly mission in the immune system , 2000, Nature.
[53] S. Conzen,et al. The glucocorticoid receptor mediates a survival signal in human mammary epithelial cells. , 2000, Cancer research.
[54] Junying Yuan,et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β , 2000, Nature.
[55] S. Korsmeyer,et al. Prevention of lymphocyte cell death in sepsis improves survival in mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[56] P. Krammer. CD95(APO-1/Fas)-mediated apoptosis: live and let die. , 1999, Advances in immunology.
[57] Sally Lehrman,et al. Virus treatment questioned after gene therapy death , 1999, Nature.
[58] Dexi Liu,et al. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA , 1999, Gene Therapy.
[59] R. Hotchkiss,et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. , 1999, Critical care medicine.
[60] S. Korsmeyer,et al. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. , 1999, Journal of immunology.
[61] I. Chaudry,et al. Does Fas ligand or endotoxin contribute to thymic apoptosis during polymicrobial sepsis? , 1999, Shock.
[62] P. Vandenabeele,et al. Non‐specific effects of methyl ketone peptide inhibitors of caspases , 1999, FEBS letters.
[63] I. Chaudry,et al. Is Fas ligand or endotoxin responsible for mucosal lymphocyte apoptosis in sepsis? , 1998, Archives of surgery.
[64] H. Oh. Emerging therapies for sepsis and septic shock. , 1998, Annals of the Academy of Medicine, Singapore.
[65] I. Chaudry,et al. Does hepatocellular injury in sepsis involve apoptosis? , 1998, The Journal of surgical research.
[66] Ute Koch,et al. Bioactive Peptide Design Based on Protein Surface Epitopes , 1997, The Journal of Biological Chemistry.
[67] R. Hotchkiss,et al. CECAL LIGATION AND PUNCTURE (CLP) INDUCES APOPTOSIS IN THYMUS, SPLEEN, LUNG, AND GUT BY AN ENDOTOXIN AND TNF‐INDEPENDENT PATHWAY , 1997, Shock.
[68] M. Carroll,et al. Complement and the immune response. , 1997, Current opinion in immunology.
[69] P. Briand,et al. ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis , 1996, Current Biology.
[70] I. Chaudry,et al. Mechanism of hepatocellular dysfunction during hyperdynamic sepsis. , 1996, The American journal of physiology.
[71] R. Lefering,et al. Steroid controversy in sepsis and septic shock: a meta-analysis. , 1995, Critical care medicine.
[72] G. Cox,et al. Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. , 1995, Journal of immunology.
[73] I. Chaudry,et al. THE INDUCTION OF ACCELERATED THYMIC PROGRAMMED CELL DEATH DURING POLYMICROBIAL SEPSIS: CONTROL BY CORTICOSTEROIDS BUT NOT TUMOR NECROSIS FACTOR , 1995, Shock.
[74] C. Hinds,et al. Elevation of systemic oxygen delivery in the treatment of critically ill patients. , 1994, The New England journal of medicine.
[75] Cohen Jj. Glucocorticoid-induced apoptosis in the thymus. , 1992 .
[76] B. Huber,et al. IL-4 and IL-2 selectively rescue Th cell subsets from glucocorticoid-induced apoptosis. , 1992, Journal of immunology.
[77] M. Heideman,et al. Anaphylatoxin formation in sepsis. , 1988, Archives of surgery.
[78] R. Komers,et al. Emerging role of Akt kinase/protein kinase B signaling in pathophysiology of diabetes and its complications. , 2005, Physiological research.
[79] G. Bernard,et al. Therapeutic intervention and targets for sepsis. , 2005, Annual review of medicine.
[80] Dieter Mesotten,et al. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. , 2004, The Journal of clinical endocrinology and metabolism.
[81] Xiaodong Wang,et al. A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death. , 2004, Science.
[82] C. Chung,et al. Pathological aspects of apoptosis in severe sepsis and shock? , 2003, The international journal of biochemistry & cell biology.
[83] B. Bistrian,et al. Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.
[84] A. Gascoigne,et al. Circulating endothelial cells in patients with septic shock. , 2001, American journal of respiratory and critical care medicine.
[85] I. Chaudry,et al. The Apoptotic Response of the Lymphoid Immune System to Trauma, Shock, and Sepsis , 2000 .
[86] L. U. G. Attinoni,et al. A TRIAL OF GOAL-ORIENTED HEMODYNAMIC THERAPY IN CRITICALLY ILL PATIENTS , 2000 .
[87] K. Asadullah,et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. , 1997, Nature medicine.
[88] J. Cohen. Glucocorticoid-induced apoptosis in the thymus. , 1992, Seminars in immunology.